CD4 and COVID-19: To assess whether exosomes of MILD COVID-19 patients induced T-cell growth by actual T-cell activation, we tested their capability to modulate the expression of middle, CD25, and late, HLA-DR, T-lymphocyte activation markers cocultured in matched CD4+ T cells.